These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 9851562)
1. Investigation of I1-imidazoline receptors using microphysiometry and molecular modelling. Musgrave IF; Hughes RA J Auton Nerv Syst; 1998 Oct; 72(2-3):137-46. PubMed ID: 9851562 [TBL] [Abstract][Full Text] [Related]
2. Novel targets and techniques in imidazoline receptor research. Musgrave IF; Hughes RA Ann N Y Acad Sci; 1999 Jun; 881():301-12. PubMed ID: 10415931 [TBL] [Abstract][Full Text] [Related]
3. Moxonidine, a centrally acting antihypertensive agent, is a selective ligand for I1-imidazoline sites. Ernsberger P; Damon TH; Graff LM; Schäfer SG; Christen MO J Pharmacol Exp Ther; 1993 Jan; 264(1):172-82. PubMed ID: 8380858 [TBL] [Abstract][Full Text] [Related]
4. A novel mechanism of action for hypertension control: moxonidine as a selective I1-imidazoline agonist. Ernsberger P; Haxhiu MA; Graff LM; Collins LA; Dreshaj I; Grove DL; Graves ME; Schäfer SG; Christen MO Cardiovasc Drugs Ther; 1994 Mar; 8 Suppl 1():27-41. PubMed ID: 8068578 [TBL] [Abstract][Full Text] [Related]
5. Imidazoline binding sites on PC12 cells and bovine chromaffin cells. Steffen G; Dendorfer A; Dominiak P Ann N Y Acad Sci; 1995 Jul; 763():157-62. PubMed ID: 7677325 [TBL] [Abstract][Full Text] [Related]
6. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors. Olmos G; Kulkarni RN; Haque M; MacDermot J Eur J Pharmacol; 1994 Sep; 262(1-2):41-8. PubMed ID: 7813577 [TBL] [Abstract][Full Text] [Related]
7. Imidazoline/guanidinium binding sites and their relation to inhibition of K(ATP) channels in pancreatic B-cells. Rustenbeck I; Herrmann C; Ratzka P; Hasselblatt A Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):410-7. PubMed ID: 9303581 [TBL] [Abstract][Full Text] [Related]
8. Imidazoline binding sites and signal transduction pathways. Musgrave IF; Krautwurst D; Schultz G Clin Exp Pharmacol Physiol; 1996; 23(10-11):990-4. PubMed ID: 8911748 [TBL] [Abstract][Full Text] [Related]
9. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells. Gargalidis-Moudanos C; Parini A J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and pharmacological evaluation of imidazoline sites I1 and I2 selective ligands. Anastassiadou M; Danoun S; Crane L; Baziard-Mouysset G; Payard M; Caignard DH; Rettori MC; Renard P Bioorg Med Chem; 2001 Mar; 9(3):585-92. PubMed ID: 11310592 [TBL] [Abstract][Full Text] [Related]
11. Role of medullary I1-imidazoline and alpha 2-adrenergic receptors in the antihypertensive responses evoked by central administration of clonidine analogs in conscious spontaneously hypertensive rats. Buccafusco JJ; Lapp CA; Westbrooks KL; Ernsberger P J Pharmacol Exp Ther; 1995 Jun; 273(3):1162-71. PubMed ID: 7791087 [TBL] [Abstract][Full Text] [Related]
12. Binding of [3H]clonidine to I1-imidazoline sites in bovine adrenal medullary membranes. Molderings GJ; Moura D; Fink K; Bönisch H; Göthert M Naunyn Schmiedebergs Arch Pharmacol; 1993 Jul; 348(1):70-6. PubMed ID: 8377842 [TBL] [Abstract][Full Text] [Related]
13. The I1-imidazoline receptor: from binding site to therapeutic target in cardiovascular disease. Ernsberger P; Friedman JE; Koletsky RJ J Hypertens Suppl; 1997 Jan; 15(1):S9-23. PubMed ID: 9050981 [TBL] [Abstract][Full Text] [Related]
14. Presynaptic imidazoline receptors and non-adrenoceptor [3H]-idazoxan binding sites in human cardiovascular tissues. Molderings GJ; Likungu J; Jakschik J; Göthert M Br J Pharmacol; 1997 Sep; 122(1):43-50. PubMed ID: 9298527 [TBL] [Abstract][Full Text] [Related]
15. Possible structural and functional relationships between imidazoline receptors and alpha 2-adrenoceptors. Hieble JP; Ruffolo RR Ann N Y Acad Sci; 1995 Jul; 763():8-21. PubMed ID: 7677390 [TBL] [Abstract][Full Text] [Related]
16. Expression of non-adrenergic imidazoline sites in chromaffin cells and mitochondrial membranes of bovine adrenal medulla. Regunathan S; Meeley MP; Reis DJ Biochem Pharmacol; 1993 Apr; 45(8):1667-75. PubMed ID: 8387303 [TBL] [Abstract][Full Text] [Related]
19. No relationship of I1- and I2-imidazoline binding sites to inhibitory effects of imidazolines on ligand-gated ion channels. An investigation in the adrenal medulla and in neuroblastoma cells. Molderings GJ; Ruppert K; Bönisch H; Göthert M Ann N Y Acad Sci; 1995 Jul; 763():420-32. PubMed ID: 7545886 [No Abstract] [Full Text] [Related]
20. Selective antihypertensive action of moxonidine is mediated mainly by I1-imidazoline receptors in the rostral ventrolateral medulla. Haxhiu MA; Dreshaj I; Schäfer SG; Ernsberger P J Cardiovasc Pharmacol; 1994; 24 Suppl 1():S1-8. PubMed ID: 7533221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]